Champions League fairytale team Bodø/Glimt close to return as 7 playoffs decide full 36-team lineup - Medicine Hat NewsMedicine Hat News
Bodø/Glimt is nearing a return to the Champions League, with seven playoffs set to determine the final 36-team lineup. Their remarkable journey continues to captivate fans.

In an exciting turn of events, Bodø/Glimt, the Norwegian club known for their remarkable Champions League journey, is on the brink of returning to the prestigious tournament. With the final seven spots in the 36-team lineup set to be determined this week, Bodø/Glimt currently holds a 3-1 advantage over Dutch newcomers NEC Nijmegen, as they prepare to host the second leg of their playoff at their home ground in the Arctic Circle.
Norwegian Rivals in the Mix
Norway may see two teams in the Champions League this season, as domestic champions Viking are tied 2-2 with Dinamo Zagreb. The Croatian side squandered an early two-goal lead in the first leg, making the upcoming match crucial for both teams. The draw ceremony for the Champions League will take place on Thursday at 6 p.m. local time in Monaco, coinciding with other playoff matches in the Europa League and Conference League.
Bodø/Glimt's Remarkable Journey
Bodø/Glimt's impressive run in last season's Champions League included victories over top clubs such as Manchester City, Atletico Madrid, and Inter Milan. This season, they began their campaign in the qualifying rounds, successfully advancing through two rounds in August. They have scored three goals in each of their three matches thus far, including a thrilling aggregate win of 6-5 against Union Saint-Gilloise. The team has retained most of its squad, with the notable exception of Denmark forward Kasper Høgh, who transferred to Celtic for a reported fee of 11 million pounds ($15 million).
As the playoffs unfold, the excitement builds for Bodø/Glimt and their potential return to the Champions League, where they will join the ranks of elite clubs such as Paris Saint-Germain, Real Madrid, and Bayern Munich.
Source: medicinehatnews.com